![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 05, 2015 6:00:56 PM
The point(s) made in the 7-2 US Supreme Court decision to send the case back to the appellate court (which lectured on, and emphasized, the obligation of the appellate justices to defer to the decisions of the trial court jury and judge on issues of fact, etc.) were EXACTLY what Chen said in his strong dissent from the 2-justice majority that hijacked our hard-fought trial court decision. These patent infringement cases are NOT to be examined de novo, says the US Supreme Court. This is judicial tradition, and it is now renewed case law. Period.
Exactly how and when the Teva principles will be applied to our Vringo case is yet to be seen---and we’ve all seen how huge multi-billion-dollar international corporations can drag things out time-wise---but we do appear to be back in the driver’s seat as a matter of law. jmho.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM